Safety and Efficacy Study of Vemurafenib and High-dose Interferon Alfa-2b in Melanoma

NCT01943422 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

7

Enrollment

OTHER

Sponsor class

Conditions

Melanoma

Interventions

DRUG: High-dose Interferon alfa-2b
DRUG: Vemurafenib

Sponsor

John Kirkwood

Collaborators

[object Object]